| DRRX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the DRRX market cap history going back to 2/26/2010:
Also see: DRRX Shares Outstanding History and DRRX YTD Return |
DRRX Market Cap History — Durect Capitalization Over Time
As of 8/8/2025 Durect has a market cap of 58.07 million. Investors often follow the DRRX market cap history to compare the size of the company over time.
This page shows DRRX market capitalization trends over time, with 56 market cap datapoints presented, dating back to 2/26/2010.
| DRRX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DRRX Historical Market Cap: -7.91% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DRRX Stock Price Chart |
| About Durect Corp |
| DURECT Corporation is a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target dysregulated deoxyribonucleic acid (DNA) methylation to transform the treatment of serious and life-threatening conditions, including acute organ injury and cancer. Larsucosterol is in clinical development for the potential treatment of alcohol-associated hepatitis, for which U.S. Food and Drug Administration (FDA) has granted a Fast Track Designation; metabolic dysfunction-associated steatohepatitis is also being explored. We show 56 historical shares outstanding datapoints in our DRRX shares outstanding history coverage, used to compute DRRX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing DRRX market cap history over the course of time is important for investors interested in comparing DRRX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of DRRX versus a peer is one thing; comparing DRRX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like DRRX can fluctuate over the course of history. With this page we aim to empower investors researching DRRX by allowing them to research the DRRX market cap history. |
| DRRX Current Stock Quote |
Quotes delayed 20 minutes  Free DRRX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| DRRX Share Performance |
| Market Cap Peers |
| Durect (DRRX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
DSGN Market Cap History DTIL Market Cap History DVA Market Cap History DVAX Market Cap History DVCR Market Cap History DWTX Market Cap History DXCM Market Cap History DYAI Market Cap History DYN Market Cap History DYNT Market Cap History More Healthcare companies » |
DRRX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
